Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 85 matching records.
85 results — page 1 of 4
- Level BClinical TrialEurope PMC
Safety and risk management in clinical trials for chronic wounds with tissue regenerative products
Clinical Trial with a reported sample of 186 on Diabetic Foot, Chronic Wound, published in Ther Adv Drug Saf (2026) — summary generated from the PubMed abstract.
- 2026
- n = 186
Ther Adv Drug Saf - Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells combined with platelet-rich plasma for periodontal regeneration: a multicenter, randomized, open-label, parallel-group comparative trial.
Clinical Trial with a reported sample of 21, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 21
Regen Ther1 citations - Level BClinical TrialPubMed
Safety and feasibility of intravenous fresh adipose-derived mesenchymal stem cells in secondary progressive multiple sclerosis: phase I/IIa clinical results.
Clinical Trial on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther1 citations - Level BClinical TrialPubMed
Autologous SVF therapy modulates neuroinflammation in ALS: phase I trial demonstrating safety and CSF biomarker dynamics.
Clinical Trial with a reported sample of 26 on Neuroinflammation, Immune Modulation, published in Front Aging Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 26
Front Aging Neurosci - Level BClinical TrialEurope PMC
An open phase I/IIa study evaluating safety, patient-reported outcomes and voice function after surgery, local administration of mesenchymal stromal cells and voice training in patients with vocal fold scarring and dysph
Clinical Trial on Scar, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level BClinical TrialPubMed
Long-term Effectiveness and Safety of Mesenchymal Stromal Cell Therapy for Radiation-Induced Hyposalivation in Head and Neck Cancer Survivors: A Randomized Phase II Trial.
Clinical Trial, published in Clin Cancer Res (2025) — summary generated from the PubMed abstract.
- 2025
Clin Cancer Res3 citations - Level BClinical TrialPubMed
A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia.
Clinical Trial on Ankle Injury, Peripheral Artery Disease, Chronic Wound, published in Int J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Int J Stem Cells - Level BClinical TrialEurope PMC
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Clinical Trial on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level BClinical TrialPubMed
Study protocol for a randomized clinical trial evaluating the safety and efficacy of autologous adipose-derived stem cell therapy for ulcers in patients with critical limb ischemia.
Clinical Trial on Peripheral Artery Disease, published in PLoS One (2025) — summary generated from the PubMed abstract.
- 2025
PLoS One - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level BClinical TrialEurope PMC
Safety of autologous nucleus pulposus cell transplantation with fibrin glue following endoscopic discectomy in chronic low back pain: a preliminary phase I trial
Clinical Trial on Back Pain, Disc Degeneration, published in BMC Musculoskelet Disord (2025) — summary generated from the PubMed abstract.
- 2025
BMC Musculoskelet Disord - Level BClinical TrialEurope PMC
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trial
Clinical Trial on Type 2 Diabetes, Chronic Inflammation, Immune Modulation, published in Am J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Am J Stem Cells - Level BClinical TrialEurope PMC
Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase I/II safety and efficacy trial
Clinical Trial on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 114
Stem Cell Res Ther - Level BClinical TrialPubMed
Initial safety outcomes of adipose-derived mesenchymal stem cell for rotator cuff tear: A 3-year pilot trial.
Clinical Trial on Tendon Injury, Rotator Cuff, Shoulder Pain, published in J Orthop (2025) — summary generated from the PubMed abstract.
- 2025
J Orthop - Level BClinical TrialPubMed
Safety and Tolerability of Intra-Articular Injection of Adipose-Derived Mesenchymal Stem Cells GXCPC1 in 11 Subjects With Knee Osteoarthritis: A Nonrandomized Pilot Study Without a Control Arm.
Clinical Trial on Knee Osteoarthritis, Osteoarthritis, published in Cell Transplant (2024) — summary generated from the PubMed abstract.
- 2024
Cell Transplant13 citations - Level BClinical TrialPubMed
Scoping review of the use of mesenchymal stem and stromal cell products in cats, Part 1: current logistics and safety.
Clinical Trial, published in J Am Vet Med Assoc (2024) — summary generated from the PubMed abstract.
- 2024
J Am Vet Med Assoc - Level BClinical TrialPubMed
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Clinical Trial on Type 2 Diabetes, Neuroinflammation, Immune Modulation, published in Trials (2024) — summary generated from the PubMed abstract.
- 2024
Trials - Level BClinical TrialPubMed
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bone
Clinical Trial with a reported sample of 14, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 14
J Transl Med10 citations - Level BClinical TrialPubMed
The investigation and comparison of the efficacy and safety of stromal vascular fraction (SVF), platelet rich plasma (PRP), and 1064-nm Q-switched Nd:YAG laser in reducing nanofat treated infraorbital dark circles and wr
Clinical Trial with a reported sample of 15 on Skin Aging, published in Skin Res Technol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 15
Skin Res Technol5 citations - Level BClinical TrialEurope PMC
Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clini
Clinical Trial, published in Basic Clin Androl (2024) — summary generated from the PubMed abstract.
- 2024
Basic Clin Androl2 citations - Level BClinical TrialEurope PMC
Comprehensive Biosafety Profile of Carbomer-Based Hydrogel Formulations Incorporating Phosphorus Derivatives
Clinical Trial, published in Gels (2024) — summary generated from the PubMed abstract.
- 2024
Gels10 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406